- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07784517
Diaphragmatic Facilitation and Upper Extremity Performance in Volleyball Players
Immediate Effects of Diaphragmatic Facilitation on Upper Extremity Performance in Volleyball Players
The diaphragm contributes to both respiration and trunk stabilization. Effective diaphragmatic function may support postural control, force transfer, and upper extremity performance during dynamic activities. However, evidence regarding the immediate effects of manual diaphragmatic facilitation on upper extremity performance in athletes remains limited.
This study aims to investigate the immediate effects of manual diaphragmatic facilitation on upper extremity performance and respiratory function in actively participating volleyball players. Participants will receive an approximately 15-minute session of manual diaphragmatic facilitation. Pulmonary function, respiratory muscle strength, and upper extremity strength, stability, and endurance will be assessed immediately before and after the intervention. Assessments will include spirometry, maximal inspiratory and expiratory pressures, the Medicine Ball Throw Test, the Closed Kinetic Chain Upper Extremity Stability Test, and the Scapular Endurance Test.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
-
Istanbul, Turquia (Türkiye), 34010
- Recrutamento
- Istinye University
-
Contato:
- Kubra Kardes, Asst.Prof
- Número de telefone: 05387115631
- E-mail: kubrakoce@gmail.com
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria:
- Aged between 18 and 30 years.
- Regularly participating in volleyball for at least one year.
- Training at least twice per week or actively participating in volleyball at the league or tournament level.
- No history of a serious upper extremity or trunk injury within the previous six months, i-including injuries affecting the shoulder, scapular region, or spine.
- No diagnosed chronic respiratory disease, including asthma, chronic obstructive pulmonary disease, or allergic bronchitis.
- Willing and able to provide written informed consent.
Exclusion Criteria:
- History of surgery involving the upper extremity, spine, or trunk within the previous six months, including shoulder arthroscopy or spinal disc surgery.
- Presence of an active musculoskeletal injury, including tendinopathy, bursitis, or ligament injury.
- Presence of a diagnosed respiratory disease, including asthma, chronic obstructive pulmonary disease, or bronchiectasis.
- Presence of a diagnosed postural or spinal deformity that may affect study assessments, including scoliosis, clinically significant kyphosis, or clinically significant lordosis.
- History of a neurological or cardiovascular disease.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Dobro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Intervention Group
Diaphragmatic Facilitation Group
|
Following a standardized dynamic warm-up, participants in the intervention group will receive a single session of manual resisted diaphragmatic facilitation.
|
|
Experimental: Control Group
Sham Control Group
|
Participants in the control group will complete the same dynamic warm-up protocol, followed by a sham intervention consisting of superficial, non-facilitatory palpation and general breathing instructions.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Forced Vital Capacity
Prazo: 4 weeks
|
Forced vital capacity is the maximum volume of air that a participant can forcibly exhale after taking the deepest possible breath.
It will be measured by spirometry and recorded in liters.
Higher values generally indicate greater ventilatory capacity, whereas lower values may indicate reduced pulmonary capacity or expiratory limitation.
|
4 weeks
|
|
Forced Expiratory Volume in One Second
Prazo: 4 weeks
|
Forced expiratory volume in one second is the volume of air that a participant can forcibly exhale during the first second of a forced expiratory maneuver.
It will be measured by spirometry and recorded in liters.
Higher values generally indicate better expiratory airflow, whereas lower values may indicate reduced expiratory airflow.
|
4 weeks
|
|
Ratio of Forced Expiratory Volume in One Second to Forced Vital Capacity
Prazo: 4 weeks
|
The ratio of forced expiratory volume in one second to forced vital capacity represents the proportion of the forced vital capacity exhaled during the first second of a forced expiratory maneuver.
It will be calculated from spirometric measurements and reported as a percentage.
Higher values generally indicate a greater proportion of air expelled during the first second, whereas lower values may indicate expiratory airflow limitation.
The results will be interpreted with consideration of age- and sex-appropriate reference values.
|
4 weeks
|
|
Maximal Inspiratory Pressure
Prazo: 4 weeks
|
Maximal inspiratory pressure will be used to assess inspiratory muscle strength, primarily reflecting the function of the diaphragm and other inspiratory muscles.
The measurement will be repeated three times, and the highest valid value will be recorded in centimeters of water.
A higher absolute pressure value indicates greater inspiratory muscle strength, whereas a lower absolute pressure value indicates weaker inspiratory muscle strength.
|
4 weeks
|
|
Maximal Expiratory Pressure
Prazo: 4 weeks
|
Maximal expiratory pressure will be used to assess expiratory muscle strength, particularly the strength of the abdominal and other expiratory muscles.
The measurement will be repeated three times, and the highest valid value will be recorded in centimeters of water.
A higher pressure value indicates greater expiratory muscle strength, whereas a lower pressure value indicates weaker expiratory muscle strength.
|
4 weeks
|
|
Medicine Ball Throw Distance
Prazo: 4 weeks
|
Upper extremity explosive power will be assessed using the Medicine Ball Throw Test.
The participant will sit with the back supported against a wall and the legs extended and will be instructed to throw the medicine ball as far as possible.
Throwing distance will be measured in meters.
A longer distance indicates greater upper extremity explosive power, whereas a shorter distance indicates lower explosive power.
|
4 weeks
|
|
Closed Kinetic Chain Upper Extremity Stability Test Score
Prazo: 4 weeks
|
Upper extremity stability, strength, power, and endurance will be assessed using the Closed Kinetic Chain Upper Extremity Stability Test.
The participant will assume a push-up position with the hands placed on two markers positioned 90 centimeters apart.
The participant will alternately move each hand across the body to touch the opposite marker during the specified test period.
The total number of valid touches will be recorded.
A higher number of touches indicates better upper extremity functional performance and stability, whereas a lower number indicates poorer performance.
|
4 weeks
|
|
Scapular Muscular Endurance Time
Prazo: 4 weeks
|
The functional endurance of the scapular stabilizing muscles will be assessed using the Scapular Muscular Endurance Test.
An appropriately sized wooden rod will be positioned between the participant's elbows while both scapulae are maintained in a neutral position.
The length of time for which the participant can maintain the standardized test position will be recorded in seconds.
A longer duration indicates greater scapular muscular endurance, whereas a shorter duration indicates lower scapular muscular endurance.
|
4 weeks
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 2025/07
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .